

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to parathyroid hormone (GO:0071107) | 6.21454949 |
| 2 | polyol transport (GO:0015791) | 6.08977216 |
| 3 | actin filament depolymerization (GO:0030042) | 5.72501093 |
| 4 | renal tubule development (GO:0061326) | 5.55138784 |
| 5 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.53743977 |
| 6 | negative regulation of metanephros development (GO:0072217) | 5.43375854 |
| 7 | cell volume homeostasis (GO:0006884) | 5.33594023 |
| 8 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.30091802 |
| 9 | lysine metabolic process (GO:0006553) | 4.74695301 |
| 10 | lysine catabolic process (GO:0006554) | 4.74695301 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.71554242 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 4.71554242 |
| 13 | nephron epithelium development (GO:0072009) | 4.70641594 |
| 14 | nephron tubule formation (GO:0072079) | 4.59766185 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.55649747 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 4.55649747 |
| 17 | collecting duct development (GO:0072044) | 4.25882218 |
| 18 | response to water (GO:0009415) | 4.11603943 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 4.07247270 |
| 20 | drug transmembrane transport (GO:0006855) | 4.05110134 |
| 21 | urate metabolic process (GO:0046415) | 3.95180976 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.90613016 |
| 23 | cysteine metabolic process (GO:0006534) | 3.90235490 |
| 24 | response to thyroid hormone (GO:0097066) | 3.85993358 |
| 25 | response to lead ion (GO:0010288) | 3.74180466 |
| 26 | homocysteine metabolic process (GO:0050667) | 3.72645135 |
| 27 | positive regulation of catenin import into nucleus (GO:0035413) | 3.70867342 |
| 28 | surfactant homeostasis (GO:0043129) | 3.69303291 |
| 29 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.68993456 |
| 30 | aspartate family amino acid catabolic process (GO:0009068) | 3.63010523 |
| 31 | cell differentiation involved in metanephros development (GO:0072202) | 3.60350490 |
| 32 | short-chain fatty acid metabolic process (GO:0046459) | 3.58327816 |
| 33 | cellular ketone body metabolic process (GO:0046950) | 3.58269677 |
| 34 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.57726891 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.55619348 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.55619348 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.55619348 |
| 38 | ERK1 and ERK2 cascade (GO:0070371) | 3.55428723 |
| 39 | kynurenine metabolic process (GO:0070189) | 3.55136279 |
| 40 | response to copper ion (GO:0046688) | 3.54887544 |
| 41 | activation of MAPKKK activity (GO:0000185) | 3.48227925 |
| 42 | response to mercury ion (GO:0046689) | 3.47913353 |
| 43 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.44312682 |
| 44 | tryptophan metabolic process (GO:0006568) | 3.41796288 |
| 45 | glutamate metabolic process (GO:0006536) | 3.40749964 |
| 46 | phosphate ion transport (GO:0006817) | 3.39618965 |
| 47 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.37661613 |
| 48 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.37661613 |
| 49 | 2-oxoglutarate metabolic process (GO:0006103) | 3.35747415 |
| 50 | drug catabolic process (GO:0042737) | 3.34134594 |
| 51 | cellular modified amino acid catabolic process (GO:0042219) | 3.33403638 |
| 52 | hyperosmotic response (GO:0006972) | 3.28903067 |
| 53 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.24612773 |
| 54 | drug transport (GO:0015893) | 3.21115907 |
| 55 | phosphate ion homeostasis (GO:0055062) | 3.18161754 |
| 56 | trivalent inorganic anion homeostasis (GO:0072506) | 3.18161754 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 3.14321216 |
| 58 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.13663460 |
| 59 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.10260358 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 3.08358871 |
| 61 | cellular response to reactive nitrogen species (GO:1902170) | 3.07727713 |
| 62 | ketone body metabolic process (GO:1902224) | 3.06465110 |
| 63 | phosphate ion transmembrane transport (GO:0035435) | 3.06167286 |
| 64 | exogenous drug catabolic process (GO:0042738) | 3.05265187 |
| 65 | protein localization to endosome (GO:0036010) | 3.03855788 |
| 66 | negative regulation of kidney development (GO:0090185) | 3.02858572 |
| 67 | cellular potassium ion homeostasis (GO:0030007) | 3.01484102 |
| 68 | bile acid biosynthetic process (GO:0006699) | 3.01245503 |
| 69 | sodium ion export (GO:0071436) | 2.99610342 |
| 70 | positive regulation of Rap GTPase activity (GO:0032854) | 2.99570110 |
| 71 | alpha-amino acid catabolic process (GO:1901606) | 2.94700803 |
| 72 | metanephric mesenchyme development (GO:0072075) | 2.94498280 |
| 73 | metanephric tubule development (GO:0072170) | 2.94469245 |
| 74 | metanephric nephron tubule development (GO:0072234) | 2.94469245 |
| 75 | glomerular basement membrane development (GO:0032836) | 2.93684935 |
| 76 | quaternary ammonium group transport (GO:0015697) | 2.92656889 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 2.91086592 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.90738138 |
| 79 | fatty acid beta-oxidation (GO:0006635) | 2.90506300 |
| 80 | aromatic amino acid family metabolic process (GO:0009072) | 2.90177299 |
| 81 | serine family amino acid catabolic process (GO:0009071) | 2.89161179 |
| 82 | acetyl-CoA metabolic process (GO:0006084) | 2.87422502 |
| 83 | chemical homeostasis within a tissue (GO:0048875) | 2.86731831 |
| 84 | glomerular visceral epithelial cell development (GO:0072015) | 2.85982680 |
| 85 | branched-chain amino acid metabolic process (GO:0009081) | 2.83783087 |
| 86 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.81813789 |
| 87 | B cell receptor signaling pathway (GO:0050853) | 2.81190464 |
| 88 | vitamin D metabolic process (GO:0042359) | 2.81042829 |
| 89 | coenzyme catabolic process (GO:0009109) | 2.79866156 |
| 90 | excretion (GO:0007588) | 2.79481995 |
| 91 | metanephric nephron epithelium development (GO:0072243) | 2.78718083 |
| 92 | succinate metabolic process (GO:0006105) | 2.77813260 |
| 93 | kidney mesenchyme development (GO:0072074) | 2.77252415 |
| 94 | regulation of early endosome to late endosome transport (GO:2000641) | 2.76346892 |
| 95 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.75256017 |
| 96 | cardiovascular system development (GO:0072358) | 2.74684167 |
| 97 | valine metabolic process (GO:0006573) | 2.74450368 |
| 98 | branched-chain amino acid catabolic process (GO:0009083) | 2.73328947 |
| 99 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.73020334 |
| 100 | fatty acid oxidation (GO:0019395) | 2.72463044 |
| 101 | complement activation, alternative pathway (GO:0006957) | 2.71541584 |
| 102 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.71234821 |
| 103 | regulation of protein activation cascade (GO:2000257) | 2.70709815 |
| 104 | cellular hyperosmotic response (GO:0071474) | 2.70231291 |
| 105 | regulation of protein localization to cell surface (GO:2000008) | 2.69982161 |
| 106 | carnitine transport (GO:0015879) | 2.69973475 |
| 107 | amino-acid betaine transport (GO:0015838) | 2.69973475 |
| 108 | organic cation transport (GO:0015695) | 2.69642660 |
| 109 | tricarboxylic acid metabolic process (GO:0072350) | 2.69193129 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 2.69161331 |
| 111 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.67872030 |
| 112 | NADH metabolic process (GO:0006734) | 2.67072641 |
| 113 | negative regulation of fibrinolysis (GO:0051918) | 2.66516266 |
| 114 | lipid oxidation (GO:0034440) | 2.66215918 |
| 115 | response to magnesium ion (GO:0032026) | 2.65948823 |
| 116 | regulation of complement activation (GO:0030449) | 2.64682038 |
| 117 | metanephric epithelium development (GO:0072207) | 2.64219144 |
| 118 | B cell homeostasis (GO:0001782) | 2.64147064 |
| 119 | adhesion of symbiont to host (GO:0044406) | 2.63905528 |
| 120 | tyrosine metabolic process (GO:0006570) | 2.63402460 |
| 121 | fatty acid catabolic process (GO:0009062) | 2.63350249 |
| 122 | mammary gland alveolus development (GO:0060749) | 2.63332733 |
| 123 | protein carboxylation (GO:0018214) | 2.63157350 |
| 124 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.63157350 |
| 125 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.62776341 |
| 126 | virion attachment to host cell (GO:0019062) | 2.61415907 |
| 127 | adhesion of symbiont to host cell (GO:0044650) | 2.61415907 |
| 128 | positive regulation of p38MAPK cascade (GO:1900745) | 2.61002087 |
| 129 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.60655199 |
| 130 | monocarboxylic acid catabolic process (GO:0072329) | 2.60619186 |
| 131 | alpha-linolenic acid metabolic process (GO:0036109) | 2.60399317 |
| 132 | positive regulation of macrophage cytokine production (GO:0060907) | 2.59841958 |
| 133 | glutathione biosynthetic process (GO:0006750) | 2.59718943 |
| 134 | regulation of cholesterol homeostasis (GO:2000188) | 2.59321241 |
| 135 | organic acid catabolic process (GO:0016054) | 2.58144070 |
| 136 | carboxylic acid catabolic process (GO:0046395) | 2.58144070 |
| 137 | renal system process (GO:0003014) | 2.57915252 |
| 138 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.56049631 |
| 139 | cellular sodium ion homeostasis (GO:0006883) | 2.55659920 |
| 140 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.54720950 |
| 141 | carnitine metabolic process (GO:0009437) | 2.54292540 |
| 142 | bile acid metabolic process (GO:0008206) | 2.53074693 |
| 143 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.52452221 |
| 144 | regulation of metanephros development (GO:0072215) | 2.50889936 |
| 145 | regulation of bile acid biosynthetic process (GO:0070857) | 2.50243368 |
| 146 | indolalkylamine metabolic process (GO:0006586) | 2.49950135 |
| 147 | beta-amyloid metabolic process (GO:0050435) | 2.49868312 |
| 148 | cellular response to nitric oxide (GO:0071732) | 2.49237146 |
| 149 | regulation of catenin import into nucleus (GO:0035412) | 2.49214587 |
| 150 | cellular response to ammonium ion (GO:0071242) | 2.48961663 |
| 151 | cell-substrate adherens junction assembly (GO:0007045) | 2.47216653 |
| 152 | focal adhesion assembly (GO:0048041) | 2.47216653 |
| 153 | fatty acid transmembrane transport (GO:1902001) | 2.47010723 |
| 154 | carnitine shuttle (GO:0006853) | 2.46024403 |
| 155 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.45739493 |
| 156 | regulation of fibrinolysis (GO:0051917) | 2.45455386 |
| 157 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.45228068 |
| 158 | bone resorption (GO:0045453) | 2.45141190 |
| 159 | dicarboxylic acid catabolic process (GO:0043649) | 2.44028262 |
| 160 | regulation of Rap GTPase activity (GO:0032317) | 2.43097448 |
| 161 | benzene-containing compound metabolic process (GO:0042537) | 2.42866940 |
| 162 | stress fiber assembly (GO:0043149) | 2.42536562 |
| 163 | glomerular epithelial cell development (GO:0072310) | 2.42397658 |
| 164 | negative regulation of sterol transport (GO:0032372) | 2.42329754 |
| 165 | negative regulation of cholesterol transport (GO:0032375) | 2.42329754 |
| 166 | pattern specification involved in kidney development (GO:0061004) | 2.42185772 |
| 167 | urea cycle (GO:0000050) | 2.42018553 |
| 168 | urea metabolic process (GO:0019627) | 2.42018553 |
| 169 | activation of Rac GTPase activity (GO:0032863) | 2.41846039 |
| 170 | L-amino acid import (GO:0043092) | 2.41382882 |
| 171 | water transport (GO:0006833) | 2.38464066 |
| 172 | ethanol oxidation (GO:0006069) | 2.38276520 |
| 173 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.37549830 |
| 174 | indole-containing compound metabolic process (GO:0042430) | 2.37353269 |
| 175 | drug metabolic process (GO:0017144) | 2.37061085 |
| 176 | COPI coating of Golgi vesicle (GO:0048205) | 2.36224935 |
| 177 | Golgi transport vesicle coating (GO:0048200) | 2.36224935 |
| 178 | negative regulation of osteoblast proliferation (GO:0033689) | 2.35382455 |
| 179 | nephron tubule development (GO:0072080) | 2.35036258 |
| 180 | renal absorption (GO:0070293) | 2.32836441 |
| 181 | negative regulation of protein activation cascade (GO:2000258) | 2.32217272 |
| 182 | high-density lipoprotein particle remodeling (GO:0034375) | 2.31851476 |
| 183 | serine family amino acid metabolic process (GO:0009069) | 2.28257097 |
| 184 | biotin metabolic process (GO:0006768) | 2.28071217 |
| 185 | membrane repolarization during action potential (GO:0086011) | 2.27694956 |
| 186 | nitrogen cycle metabolic process (GO:0071941) | 2.27683308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.69235446 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.46616423 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.13700151 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.95406508 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.87478315 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.87046858 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75158907 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.40745766 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.30756304 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27321800 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25961728 |
| 12 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.23678321 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.23305578 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13482676 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.12001024 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.09163016 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.93823235 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.85390551 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.85390551 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83098355 |
| 21 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82636363 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.82048669 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.78104989 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76854547 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76315024 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73910295 |
| 27 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.73261607 |
| 28 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.71495913 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.70349588 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70243425 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68586606 |
| 32 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.66660516 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66166103 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.63208694 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.62106220 |
| 36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.58973581 |
| 37 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56615765 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55177281 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54349145 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53826824 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53536192 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52512766 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50864193 |
| 44 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.49960546 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.47982162 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.47504055 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45656797 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42849942 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41854532 |
| 50 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41331687 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41278400 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41066976 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39817555 |
| 54 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38532840 |
| 55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37301139 |
| 56 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34407496 |
| 57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.32751002 |
| 58 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32216292 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29585755 |
| 60 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.29390063 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28700168 |
| 62 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28688023 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28472909 |
| 64 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26864536 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26844004 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26714940 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26140566 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25748892 |
| 69 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23743094 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23006716 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22862229 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21728779 |
| 73 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.21424329 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19772687 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19283180 |
| 76 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18499937 |
| 77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17204848 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16027140 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15788196 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14720506 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13867921 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13368282 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11984844 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11625994 |
| 85 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11147791 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09995126 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09995126 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09887787 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09824029 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08204315 |
| 91 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08041503 |
| 92 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.07960662 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05458089 |
| 94 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04836304 |
| 95 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04349403 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03745963 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03270526 |
| 98 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02005546 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01319348 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00869114 |
| 101 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00869114 |
| 102 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00019532 |
| 103 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00010720 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99934956 |
| 105 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99233339 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98806997 |
| 107 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98156373 |
| 108 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97116077 |
| 109 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96409740 |
| 110 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96220229 |
| 111 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94381757 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94072663 |
| 113 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93892294 |
| 114 | MAF_26560356_Chip-Seq_TH1_Human | 0.93786712 |
| 115 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.93730107 |
| 116 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91885358 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91534445 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90375920 |
| 119 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90111733 |
| 120 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.89719414 |
| 121 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88990756 |
| 122 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88840688 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88727579 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88057447 |
| 125 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87109050 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85788303 |
| 127 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85735630 |
| 128 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83988523 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83719676 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83534713 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83251608 |
| 132 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.82317660 |
| 133 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.82272404 |
| 134 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80988327 |
| 135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80848309 |
| 136 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80473672 |
| 137 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80215897 |
| 138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.79967820 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79843845 |
| 140 | AR_19668381_ChIP-Seq_PC3_Human | 0.79776775 |
| 141 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.79748704 |
| 142 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78865587 |
| 143 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78357896 |
| 144 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78244423 |
| 145 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78131413 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78114145 |
| 147 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.77970771 |
| 148 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.77393539 |
| 149 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77038062 |
| 150 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.76405283 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75226437 |
| 152 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75096608 |
| 153 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.75091987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.21725295 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.98338242 |
| 3 | MP0003300_gastrointestinal_ulcer | 4.46364699 |
| 4 | MP0005365_abnormal_bile_salt | 3.44603741 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.38652334 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.24163086 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.96779947 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.91524255 |
| 9 | MP0003195_calcinosis | 2.83364100 |
| 10 | * MP0005332_abnormal_amino_acid | 2.81063208 |
| 11 | MP0004043_abnormal_pH_regulation | 2.79526851 |
| 12 | * MP0003252_abnormal_bile_duct | 2.65619960 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.17158746 |
| 14 | MP0001765_abnormal_ion_homeostasis | 2.16617051 |
| 15 | MP0000751_myopathy | 2.04760981 |
| 16 | * MP0009643_abnormal_urine_homeostasis | 1.98060308 |
| 17 | MP0003183_abnormal_peptide_metabolism | 1.95510392 |
| 18 | MP0003091_abnormal_cell_migration | 1.86864888 |
| 19 | MP0001756_abnormal_urination | 1.86262233 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.78742702 |
| 21 | MP0004859_abnormal_synaptic_plasticity | 1.75050166 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.73069177 |
| 23 | MP0003879_abnormal_hair_cell | 1.70906362 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.68821629 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.68676116 |
| 26 | MP0000685_abnormal_immune_system | 1.68462311 |
| 27 | MP0005636_abnormal_mineral_homeostasis | 1.68048013 |
| 28 | MP0001348_abnormal_lacrimal_gland | 1.64495809 |
| 29 | MP0001958_emphysema | 1.61480236 |
| 30 | MP0003329_amyloid_beta_deposits | 1.58897033 |
| 31 | MP0005083_abnormal_biliary_tract | 1.49242542 |
| 32 | MP0005503_abnormal_tendon_morphology | 1.46409748 |
| 33 | MP0004272_abnormal_basement_membrane | 1.44886916 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.44280373 |
| 35 | MP0000003_abnormal_adipose_tissue | 1.42913014 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.41871474 |
| 37 | MP0000534_abnormal_ureter_morphology | 1.39072487 |
| 38 | MP0005275_abnormal_skin_tensile | 1.38741739 |
| 39 | MP0002118_abnormal_lipid_homeostasis | 1.36371437 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.36348776 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.30261910 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.28278296 |
| 43 | MP0000230_abnormal_systemic_arterial | 1.25610761 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.24877212 |
| 45 | MP0004130_abnormal_muscle_cell | 1.22882446 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.22145528 |
| 47 | MP0003279_aneurysm | 1.21500758 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.20756248 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.19862115 |
| 50 | MP0002136_abnormal_kidney_physiology | 1.19720658 |
| 51 | MP0004084_abnormal_cardiac_muscle | 1.19253364 |
| 52 | MP0003303_peritoneal_inflammation | 1.18003920 |
| 53 | MP0005257_abnormal_intraocular_pressure | 1.17295822 |
| 54 | MP0005387_immune_system_phenotype | 1.16621593 |
| 55 | MP0001790_abnormal_immune_system | 1.16621593 |
| 56 | MP0005375_adipose_tissue_phenotype | 1.15972581 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13010559 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.11440625 |
| 59 | MP0003959_abnormal_lean_body | 1.09655816 |
| 60 | MP0000604_amyloidosis | 1.06981495 |
| 61 | MP0005330_cardiomyopathy | 1.06270522 |
| 62 | MP0004215_abnormal_myocardial_fiber | 1.06159287 |
| 63 | MP0002822_catalepsy | 1.05852712 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.05444826 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.03673732 |
| 66 | MP0000747_muscle_weakness | 1.03271238 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.02003846 |
| 68 | MP0004885_abnormal_endolymph | 0.98640451 |
| 69 | MP0005535_abnormal_body_temperature | 0.98473876 |
| 70 | MP0001346_abnormal_lacrimal_gland | 0.98181692 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.96899635 |
| 72 | MP0005620_abnormal_muscle_contractility | 0.96281640 |
| 73 | MP0002168_other_aberrant_phenotype | 0.96074981 |
| 74 | MP0000538_abnormal_urinary_bladder | 0.95307854 |
| 75 | MP0002089_abnormal_postnatal_growth/wei | 0.91942907 |
| 76 | * MP0001270_distended_abdomen | 0.90980877 |
| 77 | MP0002108_abnormal_muscle_morphology | 0.90709910 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.90255383 |
| 79 | MP0003635_abnormal_synaptic_transmissio | 0.89062921 |
| 80 | MP0003880_abnormal_central_pattern | 0.88236822 |
| 81 | MP0003868_abnormal_feces_composition | 0.88151327 |
| 82 | * MP0005220_abnormal_exocrine_pancreas | 0.88051354 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.87965351 |
| 84 | MP0003646_muscle_fatigue | 0.87673073 |
| 85 | MP0008874_decreased_physiological_sensi | 0.87460554 |
| 86 | MP0008569_lethality_at_weaning | 0.86755664 |
| 87 | MP0005670_abnormal_white_adipose | 0.86604353 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.86455562 |
| 89 | MP0004484_altered_response_of | 0.85686497 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.85407102 |
| 91 | * MP0002928_abnormal_bile_duct | 0.85310717 |
| 92 | MP0001664_abnormal_digestion | 0.85236434 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.84862614 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.83800502 |
| 95 | MP0002295_abnormal_pulmonary_circulatio | 0.83437523 |
| 96 | MP0000767_abnormal_smooth_muscle | 0.83102510 |
| 97 | MP0002269_muscular_atrophy | 0.82216302 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.81788611 |
| 99 | MP0000462_abnormal_digestive_system | 0.80268240 |
| 100 | MP0000749_muscle_degeneration | 0.79925606 |
| 101 | MP0006054_spinal_hemorrhage | 0.79323532 |
| 102 | MP0002163_abnormal_gland_morphology | 0.78403459 |
| 103 | * MP0000609_abnormal_liver_physiology | 0.78157670 |
| 104 | MP0003283_abnormal_digestive_organ | 0.77769926 |
| 105 | MP0003795_abnormal_bone_structure | 0.76838875 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.76409028 |
| 107 | MP0004270_analgesia | 0.75955587 |
| 108 | MP0002796_impaired_skin_barrier | 0.75526425 |
| 109 | MP0005165_increased_susceptibility_to | 0.74586252 |
| 110 | MP0006138_congestive_heart_failure | 0.73906242 |
| 111 | MP0005058_abnormal_lysosome_morphology | 0.73679194 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.72784449 |
| 113 | MP0002064_seizures | 0.72713575 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 0.71924771 |
| 115 | MP0001177_atelectasis | 0.71093816 |
| 116 | MP0008004_abnormal_stomach_pH | 0.70983648 |
| 117 | MP0002006_tumorigenesis | 0.70771575 |
| 118 | MP0004085_abnormal_heartbeat | 0.70103277 |
| 119 | MP0005395_other_phenotype | 0.69297329 |
| 120 | MP0001661_extended_life_span | 0.68692657 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.68657167 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.68102797 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.67952174 |
| 124 | MP0002063_abnormal_learning/memory/cond | 0.67914709 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.67873827 |
| 126 | MP0005451_abnormal_body_composition | 0.67423661 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.67307551 |
| 128 | MP0001835_abnormal_antigen_presentation | 0.66588454 |
| 129 | MP0005388_respiratory_system_phenotype | 0.66505462 |
| 130 | MP0002133_abnormal_respiratory_system | 0.66505462 |
| 131 | * MP0002135_abnormal_kidney_morphology | 0.65910148 |
| 132 | MP0009745_abnormal_behavioral_response | 0.64486994 |
| 133 | MP0000678_abnormal_parathyroid_gland | 0.64393940 |
| 134 | MP0005508_abnormal_skeleton_morphology | 0.64334379 |
| 135 | MP0001542_abnormal_bone_strength | 0.64330815 |
| 136 | MP0003045_fibrosis | 0.62855600 |
| 137 | MP0001800_abnormal_humoral_immune | 0.62734101 |
| 138 | MP0009840_abnormal_foam_cell | 0.62047037 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.61809350 |
| 140 | * MP0001944_abnormal_pancreas_morphology | 0.60301244 |
| 141 | MP0000759_abnormal_skeletal_muscle | 0.57198319 |
| 142 | MP0005023_abnormal_wound_healing | 0.56570493 |
| 143 | MP0002971_abnormal_brown_adipose | 0.55903434 |
| 144 | MP0000681_abnormal_thyroid_gland | 0.54568738 |
| 145 | MP0009672_abnormal_birth_weight | 0.52040264 |
| 146 | MP0004510_myositis | 0.51834115 |
| 147 | MP0005000_abnormal_immune_tolerance | 0.49381058 |
| 148 | MP0000920_abnormal_myelination | 0.49168225 |
| 149 | MP0001191_abnormal_skin_condition | 0.47253672 |
| 150 | MP0002933_joint_inflammation | 0.44986857 |
| 151 | MP0004087_abnormal_muscle_fiber | 0.44714463 |
| 152 | MP0008872_abnormal_physiological_respon | 0.44563122 |
| 153 | MP0005645_abnormal_hypothalamus_physiol | 0.44020030 |
| 154 | MP0000566_synostosis | 0.43928462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 5.35195757 |
| 2 | Increased circulating renin level (HP:0000848) | 4.78000508 |
| 3 | Metabolic alkalosis (HP:0200114) | 4.70083772 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 4.50334096 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 4.33288802 |
| 6 | Ketoacidosis (HP:0001993) | 3.78702435 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 3.77490227 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.69128795 |
| 9 | Ketosis (HP:0001946) | 3.65463615 |
| 10 | Alkalosis (HP:0001948) | 3.63621281 |
| 11 | Hypomagnesemia (HP:0002917) | 3.62245236 |
| 12 | Deep venous thrombosis (HP:0002625) | 3.55761759 |
| 13 | Hyperglycinuria (HP:0003108) | 3.54219451 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 3.47588253 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.42662052 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.42362651 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 3.37733578 |
| 18 | Increased purine levels (HP:0004368) | 3.29440778 |
| 19 | Hyperuricemia (HP:0002149) | 3.29440778 |
| 20 | Polyuria (HP:0000103) | 3.25628670 |
| 21 | Abnormal urine output (HP:0012590) | 3.24367866 |
| 22 | Abnormality of purine metabolism (HP:0004352) | 3.23748750 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18245752 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.18245752 |
| 25 | Abnormality of sodium homeostasis (HP:0010931) | 3.02428729 |
| 26 | Abnormality of renal excretion (HP:0011036) | 3.01465852 |
| 27 | Abnormality of magnesium homeostasis (HP:0004921) | 2.97378676 |
| 28 | Hyperaldosteronism (HP:0000859) | 2.96440937 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 2.81848212 |
| 30 | Hyperammonemia (HP:0001987) | 2.81503170 |
| 31 | Xanthomatosis (HP:0000991) | 2.81164460 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.80756273 |
| 33 | Tetany (HP:0001281) | 2.75514107 |
| 34 | Hyperglycinemia (HP:0002154) | 2.73139669 |
| 35 | Hypokalemia (HP:0002900) | 2.73091017 |
| 36 | Renal salt wasting (HP:0000127) | 2.66255843 |
| 37 | Polydipsia (HP:0001959) | 2.63105573 |
| 38 | Abnormal drinking behavior (HP:0030082) | 2.63105573 |
| 39 | Proximal tubulopathy (HP:0000114) | 2.62214156 |
| 40 | Emphysema (HP:0002097) | 2.61576236 |
| 41 | Dehydration (HP:0001944) | 2.56280913 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.48119123 |
| 43 | Complement deficiency (HP:0004431) | 2.47450888 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.46118094 |
| 45 | Facial shape deformation (HP:0011334) | 2.44316231 |
| 46 | Potter facies (HP:0002009) | 2.44316231 |
| 47 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.42657787 |
| 48 | Abnormality of potassium homeostasis (HP:0011042) | 2.42219374 |
| 49 | Large eyes (HP:0001090) | 2.41095636 |
| 50 | Malnutrition (HP:0004395) | 2.40751168 |
| 51 | Generalized muscle weakness (HP:0003324) | 2.39183963 |
| 52 | Thin bony cortex (HP:0002753) | 2.38838417 |
| 53 | Nephrocalcinosis (HP:0000121) | 2.33821994 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.32465454 |
| 55 | Widely patent fontanelles and sutures (HP:0004492) | 2.29787224 |
| 56 | Hyperventilation (HP:0002883) | 2.29154819 |
| 57 | Hyponatremia (HP:0002902) | 2.28198988 |
| 58 | Hypotension (HP:0002615) | 2.27059332 |
| 59 | Persistence of primary teeth (HP:0006335) | 2.26155430 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.25960383 |
| 61 | Arterial tortuosity (HP:0005116) | 2.24048676 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23370819 |
| 63 | Right ventricular cardiomyopathy (HP:0011663) | 2.23066652 |
| 64 | Premature rupture of membranes (HP:0001788) | 2.22259557 |
| 65 | Protrusio acetabuli (HP:0003179) | 2.20993983 |
| 66 | Abnormality of urine glucose concentration (HP:0011016) | 2.20931565 |
| 67 | Glycosuria (HP:0003076) | 2.20931565 |
| 68 | Metabolic acidosis (HP:0001942) | 2.15804641 |
| 69 | Muscle fiber splitting (HP:0003555) | 2.15678595 |
| 70 | Late onset (HP:0003584) | 2.15464029 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.13958841 |
| 72 | Decreased circulating renin level (HP:0003351) | 2.11105156 |
| 73 | Enlarged kidneys (HP:0000105) | 2.10353548 |
| 74 | Vascular tortuosity (HP:0004948) | 2.09835761 |
| 75 | Vascular calcification (HP:0004934) | 2.09160431 |
| 76 | Tubular atrophy (HP:0000092) | 2.05751221 |
| 77 | Broad metatarsal (HP:0001783) | 2.04592294 |
| 78 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04451921 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.03536169 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.03536169 |
| 81 | Hyperlipoproteinemia (HP:0010980) | 2.03048381 |
| 82 | Rickets (HP:0002748) | 2.02873345 |
| 83 | Symptomatic seizures (HP:0011145) | 2.01892715 |
| 84 | Aortic dissection (HP:0002647) | 2.00373641 |
| 85 | Aortic aneurysm (HP:0004942) | 1.99866896 |
| 86 | Vomiting (HP:0002013) | 1.99125183 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97385483 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 1.97385483 |
| 89 | Glomerulosclerosis (HP:0000096) | 1.95566001 |
| 90 | Tubulointerstitial fibrosis (HP:0005576) | 1.94649546 |
| 91 | Nephrolithiasis (HP:0000787) | 1.94524716 |
| 92 | Lymphangioma (HP:0100764) | 1.94266162 |
| 93 | Prolonged partial thromboplastin time (HP:0003645) | 1.90318111 |
| 94 | IgA deficiency (HP:0002720) | 1.86332010 |
| 95 | Sudden death (HP:0001699) | 1.86029300 |
| 96 | Neonatal onset (HP:0003623) | 1.84114123 |
| 97 | Hypophosphatemia (HP:0002148) | 1.81723539 |
| 98 | Protuberant abdomen (HP:0001538) | 1.80589792 |
| 99 | Neonatal death (HP:0003811) | 1.80560437 |
| 100 | Neonatal short-limb short stature (HP:0008921) | 1.78667588 |
| 101 | Mitral stenosis (HP:0001718) | 1.78302403 |
| 102 | Chondrocalcinosis (HP:0000934) | 1.77864119 |
| 103 | Focal segmental glomerulosclerosis (HP:0000097) | 1.75914096 |
| 104 | Syncope (HP:0001279) | 1.75881953 |
| 105 | Adrenal overactivity (HP:0002717) | 1.75033619 |
| 106 | Lethargy (HP:0001254) | 1.74999360 |
| 107 | Bladder diverticulum (HP:0000015) | 1.72124974 |
| 108 | Sensorimotor neuropathy (HP:0007141) | 1.71684013 |
| 109 | Hyporeflexia of lower limbs (HP:0002600) | 1.71113381 |
| 110 | Back pain (HP:0003418) | 1.71083308 |
| 111 | Abnormality of the common coagulation pathway (HP:0010990) | 1.70808622 |
| 112 | Agammaglobulinemia (HP:0004432) | 1.70582000 |
| 113 | Hypercalciuria (HP:0002150) | 1.70033589 |
| 114 | Cellulitis (HP:0100658) | 1.68634070 |
| 115 | Fat malabsorption (HP:0002630) | 1.67703502 |
| 116 | Irritability (HP:0000737) | 1.67696645 |
| 117 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.66669281 |
| 118 | Abnormality of Sharpey fibers (HP:0100685) | 1.63945443 |
| 119 | Renal tubular acidosis (HP:0001947) | 1.63038931 |
| 120 | Hypobetalipoproteinemia (HP:0003563) | 1.62048234 |
| 121 | Abnormal pancreas size (HP:0012094) | 1.59263380 |
| 122 | Recurrent sinusitis (HP:0011108) | 1.55110453 |
| 123 | Recurrent bronchitis (HP:0002837) | 1.54593367 |
| 124 | Delayed epiphyseal ossification (HP:0002663) | 1.51604971 |
| 125 | Glucose intolerance (HP:0000833) | 1.51155072 |
| 126 | Mild short stature (HP:0003502) | 1.50496370 |
| 127 | Impaired platelet aggregation (HP:0003540) | 1.49973156 |
| 128 | Abnormal platelet function (HP:0011869) | 1.49973156 |
| 129 | Soft skin (HP:0000977) | 1.47896091 |
| 130 | Osteopenia (HP:0000938) | 1.46806484 |
| 131 | Wormian bones (HP:0002645) | 1.46202358 |
| 132 | Hyperphosphaturia (HP:0003109) | 1.39918960 |
| 133 | Abnormal urine phosphate concentration (HP:0012599) | 1.38776234 |
| 134 | Increased connective tissue (HP:0009025) | 1.38390291 |
| 135 | Hyperacusis (HP:0010780) | 1.37261692 |
| 136 | Metaphyseal cupping (HP:0003021) | 1.36668809 |
| 137 | Exocrine pancreatic insufficiency (HP:0001738) | 1.35315281 |
| 138 | Round ear (HP:0100830) | 1.34577744 |
| 139 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.32954546 |
| 140 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.32624788 |
| 141 | Type 1 muscle fiber predominance (HP:0003803) | 1.32430254 |
| 142 | Vertebral compression fractures (HP:0002953) | 1.31028225 |
| 143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.27893603 |
| 144 | Bronchomalacia (HP:0002780) | 1.26748538 |
| 145 | Increased variability in muscle fiber diameter (HP:0003557) | 1.26259342 |
| 146 | Recurrent lower respiratory tract infections (HP:0002783) | 1.25802967 |
| 147 | Premature birth (HP:0001622) | 1.24986922 |
| 148 | Dilatation of the ascending aorta (HP:0005111) | 1.23035404 |
| 149 | Abnormal tarsal ossification (HP:0008369) | 1.22693756 |
| 150 | Hyperextensible skin (HP:0000974) | 1.21974925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 4.93512288 |
| 2 | OXSR1 | 4.12426678 |
| 3 | WNK3 | 4.12252454 |
| 4 | PRPF4B | 2.78266824 |
| 5 | BCKDK | 2.73154949 |
| 6 | EPHA4 | 2.61981037 |
| 7 | STK39 | 2.52047854 |
| 8 | RIPK4 | 2.22704258 |
| 9 | MYLK | 2.20160908 |
| 10 | TTN | 2.10341774 |
| 11 | NEK9 | 2.01064148 |
| 12 | NTRK3 | 1.87643040 |
| 13 | ERN1 | 1.71800190 |
| 14 | INSRR | 1.56241136 |
| 15 | MAP2K4 | 1.51258968 |
| 16 | ARAF | 1.51193783 |
| 17 | TRIB3 | 1.46459082 |
| 18 | SGK223 | 1.45367732 |
| 19 | SGK494 | 1.45367732 |
| 20 | MAP3K7 | 1.42407993 |
| 21 | SMG1 | 1.42350512 |
| 22 | PAK3 | 1.36811981 |
| 23 | DAPK2 | 1.36591304 |
| 24 | TGFBR2 | 1.34058806 |
| 25 | PTK2B | 1.28782542 |
| 26 | STK38 | 1.28325038 |
| 27 | EEF2K | 1.28150906 |
| 28 | FGFR4 | 1.26830678 |
| 29 | TIE1 | 1.26509669 |
| 30 | LMTK2 | 1.23571933 |
| 31 | FER | 1.23514444 |
| 32 | PDK3 | 1.22943853 |
| 33 | PDK4 | 1.22943853 |
| 34 | MST1R | 1.22667493 |
| 35 | MAPK15 | 1.22064412 |
| 36 | MAP3K4 | 1.18415795 |
| 37 | STK38L | 1.18268875 |
| 38 | SIK1 | 1.14699826 |
| 39 | PDGFRA | 1.14137205 |
| 40 | SGK3 | 1.08236614 |
| 41 | JAK1 | 1.06561525 |
| 42 | EPHA2 | 1.06510089 |
| 43 | FGFR2 | 1.05590113 |
| 44 | PINK1 | 1.03978048 |
| 45 | CDK19 | 1.02836416 |
| 46 | WNK1 | 1.02076220 |
| 47 | FGFR3 | 0.99327991 |
| 48 | SGK2 | 0.99261339 |
| 49 | PHKG2 | 0.97394979 |
| 50 | PHKG1 | 0.97394979 |
| 51 | MET | 0.96664082 |
| 52 | PASK | 0.96537075 |
| 53 | MINK1 | 0.96525091 |
| 54 | MAP3K14 | 0.94081203 |
| 55 | PRKD3 | 0.90932685 |
| 56 | PRKCH | 0.88508598 |
| 57 | NTRK1 | 0.87641927 |
| 58 | PTK6 | 0.86659054 |
| 59 | MAP3K2 | 0.84625759 |
| 60 | KIT | 0.83567571 |
| 61 | MAP4K1 | 0.83008968 |
| 62 | PDK2 | 0.82475550 |
| 63 | DMPK | 0.81283955 |
| 64 | TBK1 | 0.80649720 |
| 65 | PTK2 | 0.80148123 |
| 66 | KSR2 | 0.79363924 |
| 67 | PDPK1 | 0.75057751 |
| 68 | MAP3K1 | 0.74949451 |
| 69 | LATS1 | 0.73861559 |
| 70 | PRKCZ | 0.72902931 |
| 71 | MAP3K12 | 0.69227897 |
| 72 | MAPK7 | 0.68879519 |
| 73 | CAMK1G | 0.68838100 |
| 74 | EPHB1 | 0.67967727 |
| 75 | DDR2 | 0.67430943 |
| 76 | NME1 | 0.67356710 |
| 77 | CAMK2A | 0.66115007 |
| 78 | TRPM7 | 0.66054109 |
| 79 | BRAF | 0.65063586 |
| 80 | ROCK1 | 0.63917109 |
| 81 | MAPK11 | 0.63562650 |
| 82 | EPHB2 | 0.61238738 |
| 83 | STK24 | 0.60503085 |
| 84 | SGK1 | 0.59459906 |
| 85 | TESK1 | 0.58852057 |
| 86 | MAP2K1 | 0.58718120 |
| 87 | RIPK1 | 0.57747316 |
| 88 | PRKD1 | 0.57389036 |
| 89 | PRKD2 | 0.56773042 |
| 90 | MARK1 | 0.55570999 |
| 91 | GSK3A | 0.55548799 |
| 92 | PRKCG | 0.55215956 |
| 93 | MAP3K9 | 0.54773114 |
| 94 | CSF1R | 0.54465670 |
| 95 | CDK12 | 0.53610484 |
| 96 | MAP2K7 | 0.53572025 |
| 97 | PIK3CG | 0.53381667 |
| 98 | PRKG2 | 0.53088781 |
| 99 | CAMK2B | 0.53043100 |
| 100 | PRKCQ | 0.52811631 |
| 101 | CDK5 | 0.52196799 |
| 102 | CAMK2G | 0.52070699 |
| 103 | PAK6 | 0.51390981 |
| 104 | SIK2 | 0.51172090 |
| 105 | GRK5 | 0.50408495 |
| 106 | LATS2 | 0.50218398 |
| 107 | MAPK12 | 0.50079329 |
| 108 | PKN2 | 0.49797445 |
| 109 | PRKCE | 0.49216039 |
| 110 | FRK | 0.48454602 |
| 111 | RET | 0.47800988 |
| 112 | CDC42BPA | 0.47775317 |
| 113 | PRKAA2 | 0.47687995 |
| 114 | MAP3K13 | 0.47563752 |
| 115 | DAPK3 | 0.45598665 |
| 116 | SCYL2 | 0.45539924 |
| 117 | ERBB4 | 0.45445878 |
| 118 | EPHA3 | 0.45159245 |
| 119 | NTRK2 | 0.45105782 |
| 120 | PRKAA1 | 0.44810450 |
| 121 | CAMKK1 | 0.43950035 |
| 122 | PDK1 | 0.43751115 |
| 123 | CAMK2D | 0.43498117 |
| 124 | ROCK2 | 0.42579111 |
| 125 | TAOK2 | 0.42436113 |
| 126 | PAK2 | 0.42218568 |
| 127 | PIK3CA | 0.41153193 |
| 128 | PKN1 | 0.40712583 |
| 129 | MOS | 0.40660340 |
| 130 | CASK | 0.40221436 |
| 131 | PRKACG | 0.40093068 |
| 132 | EIF2AK3 | 0.40084332 |
| 133 | PRKCD | 0.38255879 |
| 134 | MAPK4 | 0.33955601 |
| 135 | TYK2 | 0.33643588 |
| 136 | HIPK2 | 0.33225625 |
| 137 | RPS6KA2 | 0.32505092 |
| 138 | AKT2 | 0.32299958 |
| 139 | SYK | 0.31240052 |
| 140 | CDK9 | 0.30981740 |
| 141 | BMPR2 | 0.30249472 |
| 142 | IKBKE | 0.28554754 |
| 143 | CDK11A | 0.27713405 |
| 144 | STK3 | 0.25924398 |
| 145 | MELK | 0.25671429 |
| 146 | DAPK1 | 0.25625899 |
| 147 | UHMK1 | 0.25353334 |
| 148 | CDK15 | 0.23723150 |
| 149 | ICK | 0.23541820 |
| 150 | MTOR | 0.23132061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.90301189 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.79647696 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.60419661 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.42752087 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40379851 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38436222 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35425153 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.30237536 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29582339 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27974190 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18364284 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.15121775 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14472400 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.09548546 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08453878 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.02777710 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94250507 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82550330 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.82303956 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.74619322 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.71609432 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.70739930 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69048985 |
| 24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.66537847 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65066454 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58959699 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57699073 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.56905873 |
| 29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.52404182 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52216678 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51620058 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51456633 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51021376 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48876315 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47849852 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.46804699 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.40723520 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36853132 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34261512 |
| 40 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29593855 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.28568773 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26308142 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25769566 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.22135174 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17080103 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.15748713 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14956739 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10249087 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07158629 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06797730 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06622388 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05286976 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.04845712 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03222828 |
| 55 | Alcoholism_Homo sapiens_hsa05034 | 1.02787512 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00911305 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00733876 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00414855 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95452359 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.93436951 |
| 61 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93434255 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91454075 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90639466 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89957431 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89528875 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88576330 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86858124 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.86302474 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85277717 |
| 70 | Melanoma_Homo sapiens_hsa05218 | 0.82983240 |
| 71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82785061 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80907796 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80266866 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.78927553 |
| 75 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77636420 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.76420818 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74565300 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73946699 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73605887 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73103420 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72988693 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72596995 |
| 83 | GABAergic synapse_Homo sapiens_hsa04727 | 0.72512030 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71379585 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71157403 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71096701 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71095373 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70733998 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.70285755 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69690958 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69301450 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.68988740 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.68929259 |
| 94 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68814094 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67052446 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66793628 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66511107 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66059401 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.65894327 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65312269 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64662520 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64592431 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.64457631 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63812732 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63365097 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63152287 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63130251 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.63014049 |
| 109 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62515267 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62303104 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62289269 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60050835 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59903811 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59300114 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58940134 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58895021 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58570381 |
| 118 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58562069 |
| 119 | Circadian entrainment_Homo sapiens_hsa04713 | 0.58135807 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.55764897 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54902279 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54734417 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53697114 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53313607 |
| 125 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52948380 |
| 126 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51968001 |
| 127 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51708152 |
| 128 | Cocaine addiction_Homo sapiens_hsa05030 | 0.51458123 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51136273 |
| 130 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50800399 |
| 131 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50547811 |
| 132 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.50400741 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50368703 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50098845 |
| 135 | Endocytosis_Homo sapiens_hsa04144 | 0.50072225 |
| 136 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50061299 |
| 137 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48781040 |
| 138 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48256547 |
| 139 | Apoptosis_Homo sapiens_hsa04210 | 0.47669752 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47516037 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46238651 |
| 142 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45988484 |
| 143 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45670742 |
| 144 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45441048 |
| 145 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45139598 |
| 146 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44858033 |
| 147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44575194 |
| 148 | Tight junction_Homo sapiens_hsa04530 | 0.43900412 |
| 149 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43551564 |
| 150 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42732101 |
| 151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42568381 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41508415 |
| 153 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40640629 |
| 154 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39497621 |
| 155 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39085272 |
| 156 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38614026 |
| 157 | Taste transduction_Homo sapiens_hsa04742 | 0.38275829 |
| 158 | Morphine addiction_Homo sapiens_hsa05032 | 0.38129447 |
| 159 | Insulin resistance_Homo sapiens_hsa04931 | 0.35304912 |
| 160 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34138042 |
| 161 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33900035 |
| 162 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32998696 |
| 163 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32736764 |
| 164 | Amoebiasis_Homo sapiens_hsa05146 | 0.31862065 |
| 165 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31373505 |
| 166 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31341058 |

